Daniel J. Wolter

4.7k total citations · 1 hit paper
55 papers, 3.1k citations indexed

About

Daniel J. Wolter is a scholar working on Molecular Biology, Molecular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel J. Wolter has authored 55 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Molecular Medicine and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel J. Wolter's work include Antibiotic Resistance in Bacteria (22 papers), Bacterial biofilms and quorum sensing (21 papers) and Cystic Fibrosis Research Advances (15 papers). Daniel J. Wolter is often cited by papers focused on Antibiotic Resistance in Bacteria (22 papers), Bacterial biofilms and quorum sensing (21 papers) and Cystic Fibrosis Research Advances (15 papers). Daniel J. Wolter collaborates with scholars based in United States, Canada and Germany. Daniel J. Wolter's co-authors include Philip Lister, Nancy D. Hanson, Richard V. Goering, Lucas R. Hoffman, Jane L. Burns, Christopher E. Pope, Fred C. Tenover, Nicole Mayer-Hamblett, Éric Déziel and Linda K. McDougal and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

Daniel J. Wolter

54 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms

2009 1.4k citations Philip Lister, Daniel J. Wolter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel J. Wolter United States	25	1.7k	1.7k	478	452	417	55	3.1k
María D. Macià Spain	24	1.3k 0.7×	1.5k 0.9×	371 0.8×	230 0.5×	347 0.8×	42	2.8k
Robert E. McLaughlin United States	30	1.1k 0.7×	1.1k 0.7×	333 0.7×	487 1.1×	589 1.4×	72	3.5k
Sara Martí Spain	27	1.6k 0.9×	1.1k 0.6×	825 1.7×	200 0.4×	282 0.7×	90	2.7k
A.M. Snelling United Kingdom	14	788 0.5×	1.0k 0.6×	539 1.1×	444 1.0×	101 0.2×	17	2.5k
Kazunori Tomono Japan	30	830 0.5×	625 0.4×	363 0.8×	472 1.0×	311 0.7×	116	2.6k
Lin‐Hui Su Taiwan	33	1.3k 0.8×	716 0.4×	1.0k 2.1×	706 1.6×	288 0.7×	111	3.3k
Kusum Harjai India	36	1.2k 0.7×	2.3k 1.3×	518 1.1×	398 0.9×	140 0.3×	179	4.5k
Anders Folkesson Denmark	22	672 0.4×	1.1k 0.7×	367 0.8×	222 0.5×	101 0.2×	34	2.1k
Lingxian Yi China	13	3.5k 2.0×	987 0.6×	1.1k 2.4×	423 0.9×	770 1.8×	29	4.6k
Joanne L. Fothergill United Kingdom	30	1.1k 0.6×	1.8k 1.0×	431 0.9×	186 0.4×	72 0.2×	70	2.9k

Countries citing papers authored by Daniel J. Wolter

Since Specialization

Citations

This map shows the geographic impact of Daniel J. Wolter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Wolter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Wolter more than expected).

Fields of papers citing papers by Daniel J. Wolter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Wolter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Wolter. The network helps show where Daniel J. Wolter may publish in the future.

Co-authorship network of co-authors of Daniel J. Wolter

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Wolter. A scholar is included among the top collaborators of Daniel J. Wolter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Wolter. Daniel J. Wolter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Long, Dustin R., Elizabeth A. Holmes, Kelsi Penewit, et al.. (2024). Clinical and in vitro models identify distinct adaptations enhancing Staphylococcus aureus pathogenesis in human macrophages. PLoS Pathogens. 20(7). e1012394–e1012394. 2 indexed citations

Tang, Qing, Mimi R. Precit, Maureen K. Thomason, et al.. (2022). Thymidine starvation promotes c-di-AMP-dependent inflammation during pathogenic bacterial infection. Cell Host & Microbe. 30(7). 961–974.e6. 20 indexed citations

Hernandez, Rafael E., et al.. (2021). Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response. Cell Death and Disease. 12(3). 241–241. 21 indexed citations

Long, Dustin R., Daniel J. Wolter, Michael Lee, et al.. (2020). Polyclonality, Shared Strains, and Convergent Evolution in Chronic Cystic Fibrosis Staphylococcus Aureus Airway Infection. American Journal of Respiratory and Critical Care Medicine. 203(9). 1127–1137. 31 indexed citations

Nelson, Maria T., Daniel J. Wolter, Alexander Eng, et al.. (2020). Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome. Thorax. 75(9). 780–790. 29 indexed citations

Nelson, Maria T., Christopher E. Pope, Robyn L. Marsh, et al.. (2019). Human and Extracellular DNA Depletion for Metagenomic Analysis of Complex Clinical Infection Samples Yields Optimized Viable Microbiome Profiles. Cell Reports. 26(8). 2227–2240.e5. 109 indexed citations

Armbruster, Catherine R., Daniel J. Wolter, Meenu Mishra, et al.. (2016). Staphylococcus aureus Protein A Mediates Interspecies Interactions at the Cell Surface of Pseudomonas aeruginosa. mBio. 7(3). 83 indexed citations

Mayer-Hamblett, Nicole, Margaret Rosenfeld, Ronald L. Gibson, et al.. (2014). Pseudomonas aeruginosa In Vitro Phenotypes Distinguish Cystic Fibrosis Infection Stages and Outcomes. American Journal of Respiratory and Critical Care Medicine. 190(3). 289–297. 79 indexed citations

Mayer-Hamblett, Nicole, Bonnie W. Ramsey, Hemantha D. Kulasekara, et al.. (2014). Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis. Clinical Infectious Diseases. 59(5). 624–631. 55 indexed citations

10.

Wolter, Daniel J., Julia Emerson, Sharon McNamara, et al.. (2013). Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis. Clinical Infectious Diseases. 57(3). 384–391. 134 indexed citations

11.

Wolter, Daniel J.. (2008). Novel Mechanism of mexEF-oprN Efflux Pump Overexpression in Pseudomonas aeruginosa Without Co-Regulation of oprD Expression. 46th Annual Meeting. 4 indexed citations

12.

Wolter, Daniel J.. (2008). Discordance Between Imipenem (IPM) Resistance and oprD Expression in a Pseudomonas aeruginosa (PA) Overexpressing mexEF-oprN (EFN). 46th Annual Meeting. 1 indexed citations

13.

Wolter, Daniel J., et al.. (2008). Emergence of Carbapenem Resistance inPseudomonas aeruginosaIsolates from a Patient with Cystic Fibrosis in the Absence of Carbapenem Therapy. Clinical Infectious Diseases. 46(12). e137–e141. 29 indexed citations

14.

Wolter, Daniel J., Fred C. Tenover, & Richard V. Goering. (2007). Allelic variation in genes encoding Panton–Valentine leukocidin from community-associated Staphylococcus aureus. Clinical Microbiology and Infection. 13(8). 827–830. 24 indexed citations

15.

Lister, Philip, et al.. (2006). Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs. Journal of Antimicrobial Chemotherapy. 57(5). 999–1003. 29 indexed citations

16.

Lister, Philip & Daniel J. Wolter. (2005). Levofloxacin-Imipenem Combination Prevents the Emergence of Resistance among Clinical Isolates of Pseudomonas aeruginosa. Clinical Infectious Diseases. 40(Supplement_2). S105–S114. 39 indexed citations

17.

Wolter, Daniel J., et al.. (2004). Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Diagnostic Microbiology and Infectious Disease. 50(1). 43–50. 59 indexed citations

18.

Wolter, Daniel J.. (2004). Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiology Letters. 236(1). 137–143. 88 indexed citations

19.

Lierse, W., et al.. (1993). [Mechanoreceptors in the distal aspects of the m. vastus medialis?].. PubMed. 96(1). 41–2. 2 indexed citations

20.

Lierse, W., et al.. (1992). Das arterielle versorgungsprinzip der tibia und seine praktischen konsequenzen@@@The arterial angioarchitecture of the tibia and its clinical importance. Langenbeck s Archives of Surgery. 377(4). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact